Curtin University Homepage
  • Library
  • Help
    • Admin

    espace - Curtin’s institutional repository

    JavaScript is disabled for your browser. Some features of this site may not work without it.
    View Item 
    • espace Home
    • espace
    • Curtin Research Publications
    • View Item
    • espace Home
    • espace
    • Curtin Research Publications
    • View Item

    Ovarian cancer stem cells and their role in drug resistance

    Access Status
    Fulltext not available
    Authors
    Pieterse, Z.
    Amaya-Padilla, M.
    Singomat, T.
    Binju, M.
    Madjid, B.
    Yu, Y.
    Kaur, Pritinder
    Date
    2019
    Type
    Journal Article
    
    Metadata
    Show full item record
    Citation
    Pieterse, Z. and Amaya-Padilla, M. and Singomat, T. and Binju, M. and Madjid, B. and Yu, Y. and Kaur, P. 2019. Ovarian cancer stem cells and their role in drug resistance. International Journal of Biochemistry and Cell Biology. 106: pp. 117-126.
    Source Title
    International Journal of Biochemistry and Cell Biology
    DOI
    10.1016/j.biocel.2018.11.012
    ISSN
    1357-2725
    School
    School of Pharmacy and Biomedical Sciences
    URI
    http://hdl.handle.net/20.500.11937/74159
    Collection
    • Curtin Research Publications
    Abstract

    Ovarian cancer is typically diagnosed at advanced stages (III or IV), with metastasis ensuing at stage III. Complete remission is infrequent and is not achieved in almost half of the women diagnosed with ovarian cancer. Consequently, management and treatment of this disease is challenging as many patients are faced with tumour recurrence disseminating to surrounding organs further complicated with acquired chemo-resistance. The cancer stem cell theory proposes the idea that a drug resistant subset of tumour cells drive tumour progression, metastasis and ultimately, recurrent disease. In the ovarian cancer field, cancer stem cells remain elusive with significant gaps in our knowledge. The characteristics and specific role of ovarian cancer stem cells in recurrence still requires further research since different studies often arrive at contradictory conclusions. Here we present a review and critical analysis of current research conducted in the field of ovarian cancer stem cells and their potential role in drug resistance including several signalling pathways within these cells that affect the viability of targeted therapies.

    Related items

    Showing items related by title, author, creator and subject.

    • Mechanisms underlying acquired platinum resistance in high grade serous ovarian cancer - a mini review
      Binju, M.; Padilla, M.; Singomat, T.; Kaur, Pritinder; Suryo Rahmanto, Y.; Cohen, P.; Yu, Yu (2019)
      © 2018 Elsevier B.V. Background: Advanced epithelial ovarian cancer is one of the hardest human malignancies to treat. Standard treatment involves cytoreductive surgery and platinum-based chemotherapy, however, median ...
    • Pericytes promote malignant ovarian cancer progression in mice and predict poor prognosis in serous ovarian cancer patients
      Sinha, D.; Chong, L.; George, J.; Schlüter, H.; Mönchgesang, S.; Mills, S.; Li, J.; Parish, C.; Bowtell, D.; Kaur, Pritinder (2016)
      Purpose: The aim of this study was to investigate the role of pericytes in regulating malignant ovarian cancer progression. Experimental Design: The pericyte mRNA signature was used to interrogate ovarian cancer patient ...
    • PI3K/Akt/mTOR pathway dual inhibitor BEZ235 suppresses the stemness of colon cancer stem cells
      Chen, J.; Shao, R.; Li, F.; Monteiro, M.; Liu, Jian; Xu, Z.; Gu, W. (2015)
      © 2015 Wiley Publishing Asia Pty Ltd. Colon cancer is one of the most common cancers worldwide with high mortality. A major issue in colon cancer treatment is drug-resistance and metastasis that have been ascribed to the ...
    Advanced search

    Browse

    Communities & CollectionsIssue DateAuthorTitleSubjectDocument TypeThis CollectionIssue DateAuthorTitleSubjectDocument Type

    My Account

    Admin

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    Follow Curtin

    • 
    • 
    • 
    • 
    • 

    CRICOS Provider Code: 00301JABN: 99 143 842 569TEQSA: PRV12158

    Copyright | Disclaimer | Privacy statement | Accessibility

    Curtin would like to pay respect to the Aboriginal and Torres Strait Islander members of our community by acknowledging the traditional owners of the land on which the Perth campus is located, the Whadjuk people of the Nyungar Nation; and on our Kalgoorlie campus, the Wongutha people of the North-Eastern Goldfields.